银屑病缓解期角质层富含油酸者T细胞驱动的IL-17特征较低
研究比较接受生物制剂治疗的银屑病患者缓解期与未受累部位皮肤的脂肪酸组成,并用OKT-3激活皮肤外植体T细胞进行转录组分析。结果显示缓解期皮肤富含油酸的患者,其激活后T细胞驱动的表皮IL-17转录组特征较低。皮肤脂质组成与表皮T细胞功能相关。
要点
- 缓解期皮肤脂肪酸组成与未受累部位无进一步差异。
- 缓解期皮肤富含油酸者,T细胞激活后IL-17特征较低。
- 皮肤脂质组成与表皮T细胞功能相关。
核心结论
- 银屑病缓解期皮肤富含油酸的患者,在激活皮肤外植体T细胞后,T细胞驱动的表皮IL-17转录组特征较低。
- 皮肤脂质组成与表皮T细胞功能相关。
- 测试定制脂肪酸对皮肤驻留T细胞的调节作用可能有助于接近炎症性皮肤病的疾病消除。
研究设计与样本
- 研究纳入接受生物制剂治疗的银屑病患者,采用气相色谱/质谱分析缓解期与未受累部位的脂肪酸组成。
- 用OKT-3激活同一身体部位皮肤外植体中的T细胞,进行bulk转录组分析(Nanostring)。
主要发现
- 健康供者皮肤与银屑病患者外观正常皮肤的脂肪酸组成不同,但未受累部位与缓解期皮肤之间无进一步差异。
- 缓解期皮肤富含油酸的患者,在激活皮肤外植体T细胞后,T细胞驱动的表皮IL-17转录组特征较低。
临床怎么用
- 作者认为,测试定制脂肪酸对皮肤驻留T细胞的调节作用可能有助于接近炎症性皮肤病的疾病消除。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Relapses of psoriasis involve T cells that stem and survive in the skin. Inherited from previous flares, the tissue-resident memory T cells are epidermal IL-17-producing CD8+ and IL-22-producing CD4+ T cells. Because the capacity of resident memory T cells to take in fatty acids is essential for their residence and function, the surface composition of fatty acids may affect underlying T-cell populations. In patients treated with biologics, we used gas chromatography/mass spectrometry to decipher the fatty acid composition in both resolved and nonlesional sites. Skin T cells were activated by OKT-3 in explants from the same body sites to perform bulk transcriptomic analysis (Nanostring). The fatty acid composition differed between skin from healthy donors and normal-looking skin of patients with psoriasis but not further between nonlesional and resolved skin. Patients in whom the resolved skin was rich in oleic acid had lower T-cell-driven IL-17 epidermal transcriptomic signature upon activation of T cells in skin explants. The skin lipid composition is linked with the functions of the underlying epidermal T cells. Testing the modulating effect of custom fatty acids on skin resident T cells could help with coming closer to disease oblivion in inflammatory skin diseases.
引用
- El Mahi Y, Varin A, Vetter M, et al. Resolved Psoriasis with Abundant Oleic Acid in Stratum Corneum Exhibits Lower T-Cell-Driven IL-17 Signature. J Invest Dermatol. 2023. PMID: 37207807. doi:10.1016/j.jid.2023.04.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。